Respiratory Disease Testing Market By Test Type (Imaging Tests, Mechanical Tests, and In-Vitro Diagnostic Tests), By End-User (Hospitals, Diagnostic Centers, and Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Respiratory Disease Testing Market was valued at USD 6.782.5 million in 2023 and is expected to grow at a CAGR of 4.3% from 2024 to 2030. Respiratory testing involves various diagnostic procedures to assess lung function and identify respiratory disorders. These tests are crucial for diagnosing and monitoring conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory ailments. Respiratory diseases accounted for 7% of all global deaths in 2019, highlighting the importance of effective testing and diagnosis. The increasing prevalence of respiratory diseases, coupled with growing air pollution and smoking rates, drives the respiratory disease testing market.

Additionally, the COVID-19 pandemic has significantly heightened awareness about respiratory health, further boosting demand for testing. Technological advancements in testing equipment, such as the development of portable spirometers and AI-assisted diagnostics, contribute to market growth by improving the accessibility and accuracy of tests. Furthermore, an aging global population, more susceptible to respiratory issues, is expected to increase the demand for respiratory testing services. The market is also benefiting from increased healthcare expenditure and a growing focus on preventive care in many countries’ challenges such as the high cost of advanced testing equipment and a shortage of skilled technicians in some regions may hinder market growth. North America region held the major market share in 2023 and is expected to dominate the global Respiratory Disease Testing Market in the forecasted years.

Respiratory Disease Testing Market Key Developments:

In 2020, GE Healthcare introduced Thoracic Care Suite, a comprehensive set of eight artificial intelligence (AI) algorithms designed to

  • Detect anomalies on chest X-rays
  • Identify indications of pneumonia, which could potentially indicate COVID-19
  • Assist radiologists by flagging issues for further assessment

In May 2022, QuantuMDx Group Limited, a UK-based company specializing in point-of-care diagnostics, launched the Q-POC™ SARS-CoV-2, Flu A/B, and RSV Assay. This development aims to:

  • Expands upon their Q-POC™ SARS-CoV-2 test introduced in 2021
  • Significantly enhances the capabilities of the Q-POC™ platform
  • Demonstrates increased multiplex testing abilities

Respiratory Disease Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.3%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Respiratory Disease Testing Market Dynamics

The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and lung cancer, is a significant driver for the Respiratory Disease Testing Market. Respiratory testing plays a crucial role in the early diagnosis, monitoring, and management of these conditions, ultimately leading to higher demand for respiratory testing equipment and procedures. For instance, according to the World Health Organization, COPD is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. This high disease burden emphasizes the need for effective respiratory testing. On the other hand, there has been a significant improvement in public awareness regarding the importance of respiratory health and early detection of lung diseases. Increased education, government initiatives, and healthcare campaigns have boosted the overall demand for respiratory testing. The COVID-19 pandemic has further heightened awareness about respiratory health and the importance of lung function testing. However, the high cost of advanced respiratory testing equipment and the lack of skilled professionals to operate these devices in some regions may hinder market growth.

Respiratory Disease Testing Market Segmentation

By Test Type

  • Imaging Tests
  • Mechanical Tests
  • In-Vitro Diagnostic Tests

By End User

  • Hospitals
  • Diagnostic Centers
  • Others

Frequently Asked Questions

Respiratory Disease Testing Market was valued at USD 6.782.5 million in 2023 and is expected to grow at a CAGR of 4.3% from 2024 to 2030.

The leading players in the global Respiratory Disease Testing Market are Medtronic, COSMED SRL, GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION, GC Diagnostics Corporation, Masimo, Drägerwerk AG & Co. KGaA, Bio-Rad Laboratories Inc., bioMérieux SA, Carestream Health, Abbott, Johnson & Johnson Services Inc., Thermo Fisher Scientific Inc.

Historic years considered for the market study are 2019-2022, 2023 is considered as the base year for market estimation, and Seven years forecast is presented from 2024 – 2030.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
1.Executive Summary
2.Global Respiratory Disease Testing Market Introduction 
2.1.Global Respiratory Disease Testing Market  - Taxonomy
2.2.Global Respiratory Disease Testing Market  - Definitions
2.2.1.Type 
2.2.2.End-user
2.2.3.Region
3.Global Respiratory Disease Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Respiratory Disease Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Respiratory Disease Testing Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Imaging Tests
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Mechanical Tests
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. In-Vitro Diagnostic Tests
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Respiratory Disease Testing Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diagnostic Centers
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Respiratory Disease Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Respiratory Disease Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Imaging Tests
8.1.2.Mechanical Tests
8.1.3.In-Vitro Diagnostic Tests
8.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Diagnostic Centers
8.2.3.Others
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Respiratory Disease Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Imaging Tests
9.1.2.Mechanical Tests
9.1.3.In-Vitro Diagnostic Tests
9.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Diagnostic Centers
9.2.3.Others
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Respiratory Disease Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Imaging Tests
10.1.2.Mechanical Tests
10.1.3.In-Vitro Diagnostic Tests
10.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Diagnostic Centers
10.2.3.Others
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Respiratory Disease Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Imaging Tests
11.1.2.Mechanical Tests
11.1.3.In-Vitro Diagnostic Tests
11.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Diagnostic Centers
11.2.3.Others
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Respiratory Disease Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Imaging Tests
12.1.2.Mechanical Tests
12.1.3.In-Vitro Diagnostic Tests
12.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Diagnostic Centers
12.2.3.Others
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Medtronic
13.2.2.COSMED SRL
13.2.3.GENERAL ELECTRIC COMPANY
13.2.4.Koninklijke Philips N.V.
13.2.5.Hoffmann-La Roche Ltd
13.2.6.NIHON KOHDEN CORPORATION
13.2.7.GC Diagnostics Corporation
13.2.8.Masimo
13.2.9.Drägerwerk AG & Co. KGaA
13.2.10.Bio-Rad Laboratories Inc.
13.2.11.bioMérieux SA
13.2.12.Carestream Health
13.2.13.Abbott
13.2.14.Johnson & Johnson Services Inc.
13.2.15.Thermo Fisher Scientific Inc.
14. Research Methodology 
15. Appendix and Abbreviations 
  • Medtronic
  • COSMED SRL
  • GENERAL ELECTRIC COMPANY
  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd
  • NIHON KOHDEN CORPORATION
  • GC Diagnostics Corporation
  • Masimo
  • Drägerwerk AG & Co. KGaA
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • Carestream Health
  • Abbott
  • Johnson & Johnson Services Inc.
  • Thermo Fisher Scientific Inc.

Adjacent Markets